Cargando…
Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease
Gaucher disease (GD) is caused by mutations in the glucosylceramidase β (GBA 1) gene that confer a deficient level of activity of glucocerebrosidase (GCase). This deficiency leads to the accumulation of the glycolipid glucocerebroside in the lysosomes of cells, mainly in the monocyte/macrophage line...
Autores principales: | Bondar, Constanza, Ormazabal, Maximiliano, Crivaro, Andrea, Ferreyra-Compagnucci, Malena, Delpino, María Victoria, Rozenfeld, Paula Adriana, Mucci, Juan Marcos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297746/ https://www.ncbi.nlm.nih.gov/pubmed/28098793 http://dx.doi.org/10.3390/ijms18010112 |
Ejemplares similares
-
Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease
por: Crivaro, A., et al.
Publicado: (2023) -
Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease
por: Crivaro, Andrea N., et al.
Publicado: (2019) -
Pathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System
por: Mucci, Juan Marcos, et al.
Publicado: (2015) -
CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020) -
Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology
por: Ormazabal, Maximiliano Emanuel, et al.
Publicado: (2023)